Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder of the cortex and hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD remains unclear, the presence of β ‐amyloid (A β ) peptides in these learning and memory regions is a hallmark of AD. Therefore, the inhibition of A β peptide aggregation has been considered the primary therapeutic strategy for AD treatment. Many studies have shown that resveratrol has antioxidant, anti‐inflammatory, and neuroprotective properties and can decrease the toxicity and aggregation of A β peptides in the hippocampus of AD patients, promote neurogenesis, and prevent hippocampal damage. In addition, the antioxidant activity of resveratrol plays an important role in neuronal differentiation through the activation of silent information regulator‐1 (SIRT1). SIRT1 plays a vital role in the growth and differentiation of neurons and prevents the apoptotic death of these neurons by deacetylating and repressing p53 activity; however, the exact mechanisms remain unclear. Resveratrol also has anti‐inflammatory effects as it suppresses M1 microglia activation, which is involved in the initiation of neurodegeneration, and promotes Th2 responses by increasing anti‐inflammatory cytokines and SIRT1 expression. This review will focus on the antioxidant and anti‐inflammatory neuroprotective effects of resveratrol, specifically on its role in SIRT1 and the association with AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Main cellular routes proposed for the mechanisms of resveratrol in Alzheimer's disease. Modified from Ma et al. [72].](https://figures.cochat.ai/paper-figures/298b13e31ae74366bf246f40fc9ced35/neuroprotective-mechanisms-of-resveratrol-in-alzheimers-disease-role-of-sirt1-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, SIRT1 inhibits Aβ production and neuroinflammation and prevents neuronal apoptosis in AD models.414”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
RetractedMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 7×
“Some neurodegenerative diseases, such as AD, are associated with oxidative stress and neuroinflammation, and proteins that are closely related to this neurological disorder (i.e., AMPK, SIRT1, and PGC-1α) can be modulated by resveratrol [152]; however, there are few clinical studies on resveratrol in AD patients.”
BackgroundInfluentialModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“vation and had strong neuroprotective effects [68, 155].”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“However, oxidative stress is also an important event in the pathogenesis of AD [89], as the generation and accumulation of ROS and reactive nitrogen species can accelerate fibrillization, increase the toxicity of Aβ, and promote neuronal death and neurodegeneration [90–93].”
BackgroundHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Thus, showing a dose-dependent effect, resveratrol was able to activate AMPK independently of SIRT1 [116].”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
“Other important antioxidant agents being evaluated as possible AD treatment options include ascorbyl palmitate [234], coenzyme Q [235], lipoic acid [236], resveratrol [237], silibinin [238] and gintonin [239].”
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
Espíndola, K. M. M., Ferreira, R. G., Narvaez, L. E. M., Silva Rosario, A. C. R., da Silva, A. H. M., Silva, A. G. B., Vieira, A. P. O., & Monteiro, M. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00541 · Cited by 610
Self-citationHippocampus and its involvement in Alzheimer’s disease: a review
Rao, Y. L., Ganaraja, B., Murlimanju, B. V., Joy, T., Krishnamurthy, A., & Agrawal, A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03123-4 · Cited by 573
“Hence, SIRT1 regulates neuronal survival, insulin sensitivity, glucose metabolism, and mitochondrial biogenesis and thus maintains neuronal homeostasis (Gomes et al. 2018; Satoh and Imai 2014; Guarente 2013).”
BackgroundAstrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Singh, D. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02565-0 · Cited by 569
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
Management of oxidative stress and other pathologies in Alzheimer’s disease
Simunkova, M., Alwasel, S. H., Alhazza, I. M., Jomova, K., Kollar, V., Rusko, M., & Valko, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02538-y · Cited by 303
Mechanisms and roles of mitophagy in neurodegenerative diseases
Wang, Y., Liu, N., & Lu, B. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13140 · Cited by 213
Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy
Zambrano, A., Molt, M., Uribe, E., & Salas, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133374 · Cited by 210
“Furthermore, RSV is known as an activator of SIRT1 and has been related to diabetes progress as a target for its treatment [135,136], inflammation, and neuroprotection [137].”
BackgroundRelevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
de Gregorio, E., Colell, A., Morales, A., & Marí, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113858 · Cited by 197
“Because of this, it would also be interesting to explore the benefits of SIRT1 modulators in age-associated diseases, which share an inflammatory base and high levels of oxidative stress, such as COPD (chronic obstructive pulmonary disease) or Alzheimer’s disease [180].”
BackgroundSIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
Manjula, R., Anuja, K., & Alcain, F. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585821 · Cited by 195
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 180
Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
Pritam, P., Deka, R., Bhardwaj, A., Srivastava, R., Kumar, D., Jha, A. K., Jha, N. K., Villa, C., & Jha, S. K. (2022) · Biology · doi:10.3390/biology11020212 · Cited by 169
“Resveratrol ● Helps in decreasing the production of Aβ peptides in vitro ● Helps in the improvement of memory deficit and cognitive impairment in experimental animal models ● Reduces the level of MDA in an animal model ● Protects cells from Aβ-induced toxicity in vitro [84,85] • Inhibits Aβ aggregation in vitro • Redu…”
BackgroundAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“414 Correspondingly, the sirtuin family adjusts pathways related to mitochondrial biogenesis and dysfunction, oxidative stress and α -syn aggregation in individuals with PD. 415 Unexpect-edly, SIRT regulates TDP-43 posttranslational modi fi cations, reducing the aggregation propensity via…”
Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
Arbo, B. D., André-Miral, C., Nasre-Nasser, R. G., Schimith, L. E., Santos, M. G., Costa-Silva, D., Muccillo-Baisch, A. L., & Hort, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00103 · Cited by 154
“These effects may play an important role in protecting neurons from oxidative damage, prevent Aβ toxicity and reduce inflammatory cytokines production by microglia, contributing to improving memory function (Gomes et al., 2018).”
BackgroundBhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00369 · Cited by 145
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Qu, Z., Sun, J., Zhang, W., Yu, J., & Zhuang, C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.028 · Cited by 137
Zhao, Q., Tian, Z., Zhou, G., Niu, Q., Chen, J., Li, P., Dong, L., Xia, T., Zhang, S., & Wang, A. (2020) · Theranostics · doi:10.7150/thno.42387 · Cited by 139
“And a wide range of scientific evidence showed the major neuroprotective mechanisms of RSV were associated with SIRT1 activation [19].”
BackgroundAntioxidant Therapeutic Strategies in Neurodegenerative Diseases
Morén, C., deSouza, R. M., Giraldo, D. M., & Uff, C. E. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169328 · Cited by 135
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125
SIRT1 and SIRT6: The role in aging-related diseases
You, Y., & Liang, W. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166815 · Cited by 142
Clinical Application of Antioxidants to Improve Human Oocyte Mitochondrial Function: A Review
Rodríguez-Varela, C., & Labarta, E. (2020) · Antioxidants · doi:10.3390/antiox9121197 · Cited by 130
Blaikie, L., Kay, G., & Kong Thoo Lin, P. (2019) · MedChemComm · doi:10.1039/c9md00337a · Cited by 112
Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases
Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109
Cosín-Tomàs, M., Senserrich, J., Arumí-Planas, M., Alquézar, C., Pallàs, M., Martín-Requero, Á., Suñol, C., Kaliman, P., & Sanfeliu, C. (2019) · Nutrients · doi:10.3390/nu11081764 · Cited by 105
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Al-Kuraishy, H. M., Al-Gareeb, A. I., Alsayegh, A. A., Hakami, Z. H., Khamjan, N. A., Saad, H. M., Batiha, G. E., & WAARD, M. M. D. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03817-4 · Cited by 113
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing
Ajoolabady, A., Aslkhodapasandhokmabad, H., Aghanejad, A., Zhang, Y., & Ren, J. T. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101129 · Cited by 106
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
Jang, J. Y., Im, E., & Kim, N. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213689 · Cited by 112
Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease
Llanos-González, E., Henares-Chavarino, Á. A., Pedrero-Prieto, C. M., García-Carpintero, S., Frontiñán-Rubio, J., Sancho-Bielsa, F. J., Alcain, F. J., Peinado, J. R., Rabanal-Ruíz, Y., & Durán-Prado, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01444 · Cited by 96
“The compound IRL-1620, an endothelin receptor type B agonist, stimulates the clearance of Aβ and cerebral blood flow, reducing OS and improving memory impairment in rat models (Briyal et al., 2014, 2015; Pozhilenkova et al., 2017; Gulati et al., 2018).”
BackgroundFranco, G. A., Interdonato, L., Cordaro, M., Cuzzocrea, S., & Paola, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087318 · Cited by 116
Islam, F., Nafady, M. H., Islam, M. R., Saha, S., Rashid, S., Akter, A., Harun-Or-Rashid, M., Akhtar, M. F., Perveen, A., Ashraf, G. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02859-7 · Cited by 102
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Kisková, T., Kubatka, P., Büsselberg, D., & Kassayová, M. (2020) · Biomolecules · doi:10.3390/biom10010161 · Cited by 94
Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
dos Santos, S. M., Romeiro, C. F. R., Rodrigues, C. A., Cerqueira, A. R. L., & Monteiro, M. C. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8409329 · Cited by 88
“Another altered mitochondrial pathway in AD is related to the sirt3 protein, a member of the sirtuin family of proteins responsible for epigenetic regulation, chromatin integrity, regulation of metabolism, and longevity, as well as playing a role in aging [17].”
BackgroundSelf-citationMediterranean diet and cognitive function: From methodology to mechanisms of action
Siervo, M., Shannon, O. M., Llewellyn, D. J., Stephan, B. C., & Fontana, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.018 · Cited by 86
Chiu, H.-F., Venkatakrishnan, K., & Wang, C.-K. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2020.03.008 · Cited by 85
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Brockmueller, A., Sameri, S., Líšková, A., Zhai, K., Varghese, E., Samuel, S. M., Büsselberg, D., Kubatka, P., & Shakibaei, M. (2021) · Cancers · doi:10.3390/cancers13020188 · Cited by 91
Oxidative stress: A target to treat Alzheimer's disease and stroke
Briyal, S., Ranjan, A. K., & Gulati, A. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105509 · Cited by 94
He, N., Shen, G., Jin, X., Li, H., Wang, J., Xu, L., Chen, J., Cao, X., Fu, C., Shi, D., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106377 · Cited by 90
SIRT1 Regulation in Ageing and Obesity
Pardo, P. S., & Boriek, A. M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111249 · Cited by 98
Resveratrol: A Review on the Biological Activity and Applications
Bejenaru, L. E., Biţă, A., Belu, I., Segneanu, A., Radu, A., Dumitru, A., Ciocîlteu, M. V., Mogoşanu, G. D., & Bejenaru, C. (2024) · Applied Sciences · doi:10.3390/app14114534 · Cited by 101
“Because of the anti-in fl ammatory action, it inhibits M1 microglia activation, which plays a part in the induction of neurodegeneration and stimulates Th2 responses by enhancing anti-in fl ammatory cytokines and SIRT1 [136,137].”
Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Disorders
Wu, Y., & Hsieh, H. (2022) · Antioxidants · doi:10.3390/antiox11050923 · Cited by 91
“In addition, its major neuroprotective function in AD results from its anti-protein aggregation and anti-amyloidogenesis properties through the abolishment of neurofibrillary tau protein tangles or Aβ protein formation and deposition; thus, it is able to improve brain cognition function [111,112].”
BackgroundBhat, B. A., Almilaibary, A., Mir, R. A., Aljarallah, B. M., Mir, W. R., Ahmad, F., & Mir, M. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.884345 · Cited by 95
Shaito, A. A., Al‐Mansoob, M., Ahmad, S. M. S., Haider, M. Z., Eid, A. H., Posadino, A. M., Pintus, G., & Giordo, R. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221012122855 · Cited by 96
Tang, X., Zhao, Y., Zhou, Z., Yan, J., Zhou, B., Chi, X., Luo, A., & Li, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9018624 · Cited by 84
“Furthermore, activation of SIRT1 with resveratrol, a natural polyphenol agonist of SIRT1, mitigated neuronal injury by regulating the expression of BDNF in animal models of neuro-degenerative diseases [32 – 36].”
Tang, X., Wang, X., Fang, G., Zhao, Y., Yan, J., Zhou, Z., Sun, R., Luo, A., & Li, S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108579 · Cited by 84
HIV TAT-mediated microglial senescence: Role of SIRT3-dependent mitochondrial oxidative stress
Thangaraj, A., Chivero, E. T., Tripathi, A., Singh, S., Niu, F., Guo, M.-L., Pillai, P., Periyasamy, P., & Buch, S. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101843 · Cited by 76
Józkowiak, M., Hutchings, G., Jankowski, M., Kulcenty, K. I., Mozdziak, P. E., Kempisty, B., Spaczyński, R., & Piotrowska‐Kempisty, H. (2020) · Cells · doi:10.3390/cells9061418 · Cited by 74
“anti-inflammatory effect via suppression of M1 microglia activation, enhancement of Th2 responses and promotion of anti-inflammatory cytokine and SIRT-1 expression [52]”
BackgroundThe Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 74
“, resveratrol prevents oxidative stress and neuroinflammation by activating SIRT1, inhibits the tauopathy by interfering with the midline 1-protein phosphatase 2A complex, improves learning and long-term memory formation by enhancing BDNF expression, and prevents the neuronal cell death by attenuating apoptosis via Ak…”
BackgroundZhou, J., Yang, Z., Shen, R., Zhong, W., Zheng, H., Chen, Z.-G., Tang, J., & Zhu, J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.620683 · Cited by 85
RetractedDiabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Potenza, M. A., Sgarra, L., Desantis, V., Nacci, C., & Montagnani, M. (2021) · Antioxidants · doi:10.3390/antiox10081257 · Cited by 87
“Rapamycin (a potent and selective mTOR inhibitor), latrepirdine and nicotinamide are among compounds currently studied as regulators of the autophagy pathway for their potential use in AD [233].”
BackgroundArabzadeh, A., Mortezazadeh, T., Aryafar, T., Gharepapagh, E., Majdaeen, M., & Farhood, B. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02099-0 · Cited by 82
Yang, A. J. T., Bagit, A., & MacPherson, R. E. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094628 · Cited by 83
“anti-inflammatory and anti-oxidative activity through interacting with downstream target proteins [85]: Zou et al.”
BackgroundGadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 68
“The drugs which targets more than one pathway must be tested for AD treatment such as resveratrol not only act via autophagy stimulation but also shows anti‐inflammatory, antioxidant, and amyloid inhibition activity.(473) Activation of autophagy is a crucial part of the cellular response to oxidative stress induced by…”
BackgroundThe role of nutrition in Alzheimer’s disease
Śliwińska, S., & Jeziorek, M. (2021) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2021.0154 · Cited by 94
Rao, Y. L., Ganaraja, B., Marathe, A., Manjrekar, P., Joy, T., Ullal, S. D., Pai, M. M., & Murlimanju, B. V. (2021) · 3 Biotech · doi:10.1007/s13205-021-02879-5 · Cited by 77
“Brain is the most susceptible organ for oxidative stress due to its high oxygen consumption (Gomes et al. 2018).”
BackgroundResultVelagapudi, R., Lepiarz‐Raba, I., El‐Bakoush, A., Katola, F. O., Bhatia, H. S., Fiebich, B. L., & Olajide, O. A. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801237 · Cited by 78
Resveratrol—A Promising Therapeutic Agent with Problematic Properties
Radeva, L., & Yoncheva, K. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010134 · Cited by 81
Dietary Mitophagy Enhancer: A Strategy for Healthy Brain Aging?
Varghese, N., Werner, S., Grimm, A., & Eckert, A. (2020) · Antioxidants · doi:10.3390/antiox9100932 · Cited by 68
Fan, R., Peng, X., Xie, L., Dong, K., Ma, D., Xu, W., Shi, X., Zhang, S., Chen, J., Yu, X., et al. (2022) · Aging Cell · doi:10.1111/acel.13704 · Cited by 63
“The correlation of SIRT1 with the molecules participating in various signaling networks (NF- κB, P53, PGC1α, and FoxOs) has been comprehensively reviewed in the literature (Chen, Zhou, et al., 2020; Gomes et al., 2018).”
BackgroundTherapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Zhang, M., & Tang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114474 · Cited by 74
Sirtuins, brain and cognition: A review of resveratrol effects
Moraes, D. S., Moreira, D. C., Andrade, J. M. O., & Santos, S. H. S. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.06.004 · Cited by 70
“Other results are the decrease in the expression of the amyloid precursor protein and the improvement of the special working memory (Gomes et al., 2018).”
BackgroundFunctional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 73
Polyphenols and neurodegenerative diseases: focus on neuronal regeneration
Moradi, S. Z., Jalili, F., Farhadian, N., Joshi, T., Wang, M., Zou, L., Cao, H., Farzaei, M. H., & Xiao, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1865870 · Cited by 67
Rahman, M. A., Rahman, M. S., Rahman, M. H., Rasheduzzaman, M., Mamun-Or-Rashid, A., Uddin, M. J., Rahman, M. R., Hwang, H., Pang, M.-G., & Rhim, H. (2020) · Biomedicines · doi:10.3390/biomedicines9010005 · Cited by 62
Grabarczyk, M., Szczepańska, W., Czpakowska, J., Smolińska, E., Szychowska, A., Glabinski, A. R., & Szpakowski, P. (2024) · Antioxidants · doi:10.3390/antiox13111364 · Cited by 69
Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V., Lukiw, W. J., & Strosznajder, J. B. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61
Gao, Y., Zhang, N., Lv, C., Li, N., Li, X., & Li, W. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191303 · Cited by 63
“Also, the antioxidant and anti-inflammatory effects of Res had been proven to have a strong protective effect on the nerves of patients with AD[24,25].”
Shayganfard, M. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00491-3 · Cited by 66
“Currently, multiple factors including inflammation, oxidative stress, immune dysfunction, mitochondrial dysfunction, and environmental toxicities have been reported to be involved in psychiatric disorders like ASD [64, 65].”
BackgroundAzargoonjahromi, A., & Abutalebian, F. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00792-1 · Cited by 66
Resveratrol: A Vital Therapeutic Agent with Multiple Health Benefits
Kaur, A., Tıwarı, R., Tiwari, G., & Ramachandran, V. (2021) · Drug Research · doi:10.1055/a-1555-2919 · Cited by 69
“According to these findings, RSV therapy may enhance cardiovascular function by lowering myocardial ischemia-reperfusion damage, vasodilation, and atherosclerosis [59].”
BackgroundGandy, K. A. O., Zhang, J., Nagarkatti, P., & Nagarkatti, M. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09842-5 · Cited by 59
Epigenetic Regulation of Neuroinflammation in Alzheimer’s Disease
Ma, Y., Wang, W., Liu, S., Qiao, X., Xing, Y., Zhou, Q., & Zhang, Z. (2023) · Cells · doi:10.3390/cells13010079 · Cited by 61
“…of AD patients is signi fi cantly reduced compared with that of normal samples, which may be associated with A β formation as well as tau aggregation in AD brains [121,122]. reduced compared with that of normal samples, which may be associated with as well as tau aggregation in AD brains [121,122].”
BackgroundNutrition, gut microbiota, and alzheimer’s disease
Romanenko, M., Kholin, V., Koliada, A., & Vaiserman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.712673 · Cited by 56
Ghosh, S., Durgvanshi, S., Agarwal, S., Raghunath, M., & Sinha, J. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429011823 · Cited by 58
Neuroinflammation in pathogenesis of Alzheimer’s disease: Phytochemicals as potential therapeutics
Vaiserman, A., Koliada, A., & Lushchak, O. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111259 · Cited by 57
Nandave, M., Acharjee, R., Bhaduri, K., Upadhyay, J., Rupanagunta, G. P., & Ansari, M. N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124581 · Cited by 63
Bartra, C., Yuan, Y., Vuraić, K., Valdés-Quiroz, H., Garcia-Baucells, P., SLEVIN, M. A., Pastorello, Y., Sunol, C. E., & Sanfeliu, C. (2024) · Antioxidants · doi:10.3390/antiox13020177 · Cited by 62
“Resveratrol protective mechanisms against activation to proinflammatory phenotype by mCRP was confirmed in primary mixed glial cultures.”
BackgroundAnnunziata, G., Sureda, A., Orhan, İ. E., Battino, M. A., Arnone, A., Jiménez‐García, M., Capó, X., Cabot, J., Sanadgol, N., Giampieri, F., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.004 · Cited by 59
Maternal Resveratrol Supplementation Prevents Cognitive Decline in Senescent Mice Offspring
Izquierdo, V., Palomera-Ávalos, V., López-Ruiz, S., Canudas, A.-M., Pallàs, M., & Griñán-Ferré, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051134 · Cited by 55
“Resveratrol also protects the brain in different neurological conditions, such as AD and Parkinson’s Disease (PD) [28-30].”
BackgroundDietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
Dziedziak, J., Kasarełło, K., & Cudnoch‐Jędrzejewska, A. (2021) · Antioxidants · doi:10.3390/antiox10111743 · Cited by 62
“Beneficial effects of the use of resveratrol in AD patients have been widely described [50,51].”
BackgroundPlant Fortification of the Diet for Anti-Ageing Effects: A Review
Dhanjal, D. S., Bhardwaj, S., Sharma, R., Bhardwaj, K., Kumar, D., Chopra, C., Nepovimová, E., Singh, R., & Kuča, K. (2020) · Nutrients · doi:10.3390/nu12103008 · Cited by 61
“Studies have found it to be effective in the treatment of various diseases, including Alzheimer’s and cardiovascular disease [120].”
BackgroundLiu, J., Huang, J., Zhang, Z., Zhang, R., Sun, Q., Zhang, Z., Liu, Y., & Ma, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3593294 · Cited by 63
“Recently, SIRT1 was found to play an important role in Alzheimer ’ s disease and Parkinson ’ s disease [30, 31].”
Sirt1 Activity in the Brain: Simultaneous Effects on Energy Homeostasis and Reproduction
D’Angelo, S., Mele, E., Di Filippo, F., Viggiano, A., & Meccariello, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031243 · Cited by 51
“Resveratrol can indirectly stimulate Sirt1 expression and lead to neuro-protection in Alzheimer’s disease [128,129].”
BackgroundThe Role of Sirtuin 1 (SIRT1) in Neurodegeneration
Razick, D., Akhtar, M., Wen, J., Alam, M., Dean, N., Karabala, M., Ansari, U., Ansari, Z., Tabaie, E. A., & Siddiqui, S. (2023) · Cureus · doi:10.7759/cureus.40463 · Cited by 78
“AD treatment has been of particular interest as there is evidence that resveratrol can decrease the aggregation of Aβ peptides in the hippocampus, prevent hippocampal damage, and promote neurogenesis [58].”
BackgroundTanaka, M., Saitô, S., Inoue, T., Satoh‐Asahara, N., & Ihara, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092139 · Cited by 50
“Biochemical and immunocytochemical analyses revealed that the addition of taxifolin to the in vitro culture of these cells upregulated both the expression and the activity levels of SIRT1 [48], a deacetylase involved in the growth, differentiation, and survival of neurons [54].”
BackgroundMohsenpour, H., Pesce, M., Patruno, A., Bahrami, A., Pour, P. M., & Farzaei, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020833 · Cited by 50
“Besides, accumulating evidence indicated that RES treatment exerted neuroprotection against various brain disorders [247–249], including neurodegenerative diseases [250–252] such as Parkinson’s, Alzheimer’s, and Huntington’s diseases [253,254].”
BackgroundEmerging potential of cannabidiol in reversing proteinopathies
Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 51
“, 2018; Lipina and Hundal, 2016), thus maintain an equilibrium state between the redox system and pro-oxidant state (Gomes et al., 2018; Llanos-González et al., 2020).”
BackgroundRecent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Singh, R., Panghal, A., Jadhav, K., Thakur, A., Verma, R. K., Singh, C., Goyal, M., Kumar, J., & Namdeo, A. G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04256-8 · Cited by 55
“Resveratrol has been shown to have antioxidant capabilities by lowering concentrations of lipid peroxidation adducts and nitrite and increasing GSH levels [204].”
Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 49
Chen, Y., Sun, Y., Luo, Z., Lin, J., Qi, B., Kang, X., Ying, C., Guo, C., Yao, M., Chen, X., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.860364 · Cited by 55
“…regulatory relationships in the organization of the locomotor system at single-cell resolution, thereby providing a plausible explanation for the differential expression of miRNAs in blood as a result of the exercise (Holland et al., 2020; Chen Y. et al., 2021; Wen-Jin et al., 2021).”
BackgroundRole of Phytonutrients in the Prevention and Treatment of Chronic Diseases: A Concrete Review
Tufail, T., Fatima, S., Ain, H. B. U., Ikram, A., Noreen, S., Ребезов, М. Б., AL-Farga, A. M., Saleh, R. A., & Shariati, M. A. (2025) · ACS Omega · doi:10.1021/acsomega.4c02927 · Cited by 58
Synthesis and neuroprotective effects of novel chalcone-triazole hybrids
Sooknual, P., Pingaew, R., Phopin, K., Ruankham, W., Prachayasittikul, S., Ruchirawat, S., & Prachayasittikul, V. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104384 · Cited by 47
El-Fatah, I. M. A., Abdelrazek, H. M. A., Ibrahim, S. M., Abdallah, D. M., & El-Abhar, H. S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105082 · Cited by 52
Mokhtari, T. (2022) · Phytotherapy Research · doi:10.1002/ptr.7551 · Cited by 48
Fehsel, K., & Christl, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101592 · Cited by 47
Autophagy induction in the treatment of Alzheimer's disease
Schmukler, E., & Pinkas‐Kramarski, R. (2020) · Drug Development Research · doi:10.1002/ddr.21605 · Cited by 43
“Another activator of autophagy, also acting through the AMPK/mTORC1 pathway, is resveratrol, which was reported to reduce Aβ toxicity and to improve cognitive function mainly in AD animal models (Gomes et al., 2018).”
BackgroundResveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies
Puranik, N., Kumari, M., Tiwari, S., Dhakal, T., & Song, M. (2025) · Nutrients · doi:10.3390/nu17152557 · Cited by 55
Vasconcelos, T., Araújo, F., Lopes, C., Loureiro, A. I., das Neves, J., Marques, S., & Sarmento, B. F. C. C. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105011 · Cited by 41
Yan, J., Luo, A., Sun, R., Tang, X., Zhao, Y., Zhang, J., Zhou, B., Zheng, H., Yu, H., & Li, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4635163 · Cited by 45
Metadata
- Authors
- Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C.
- Affiliations
- Universidade Federal do Pará (BR)
- Corresponding author
- Monteiro, Marta Chagas
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 8152373-8152373
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC6232815
- OpenAlex
- W2898838755
- Cited by
- 403
- References
- 170
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 52 · 2023: 58 · 2022: 58 · 2021: 54 · 2020: 64 · 2019: 24
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- resveratrol, Alzheimer's disease, SIRT1, neuroprotection, amyloid-beta aggregation, antioxidant activity, anti-inflammatory activity, microglial activation, M1 microglia, Th2 immune response, p53 deacetylation, neuronal apoptosis, neurogenesis, hippocampus
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Antioxidants, Humans, Neuroprotective Agents, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.